Marlan D. Walker - 12 Apr 2023 Form 4/A - Amendment Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Chief Executive Officer
Signature
/s/ Marlan D. Walker
Issuer symbol
TXMD
Transactions as of
12 Apr 2023
Net transactions value
-$2,518
Form type
4/A - Amendment
Filing time
04 May 2023, 16:38:07 UTC
Date Of Original Report
14 Apr 2023
Previous filing
23 Feb 2023
Next filing
07 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise $0 +1,010 +7.8% $0.000000 14,041 26 Apr 2023 Direct F1
transaction TXMD Common Stock Options Exercise $0 +1,734 +16% $0.000000 12,307 26 Apr 2023 Direct F1
transaction TXMD Common Stock Sale $2,518 -692 -5.6% $3.64 11,615 26 Apr 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -1,010 -100% $0.000000* 0 26 Apr 2023 Common Stock 1,010 $0.000000 Direct F3
transaction TXMD Restricted Stock Units Options Exercise $0 -1,734 -33% $0.000000 3,466 26 Apr 2023 Common Stock 1,734 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The beneficially owned shares have been adjusted as the restricted stock units previously reported as settled on April 12, 2023 were not settled on that date. The restricted stock units settled on April 26, 2023.
F2 The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
F3 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in three equal installments annually, becoming fully vested on March 30, 2023.
F4 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.